Ensign Peak Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
|
|||||
|
2025
Q1 | $1.66M | Buy |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $2.8M | Buy |
|
|||||
|
2024
Q2 | $3.25M | Buy |
|
|||||
|
2024
Q1 | $2.31M | Buy |
|
|||||
|
2023
Q4 | $2.34M | Hold |
|
|||||
|
2023
Q3 | $2.1M | Hold |
|
|||||
|
2023
Q2 | $1.9M | Hold |
|
|||||
|
2023
Q1 | $1.66M | Sell |
|
|||||
|
2022
Q4 | $2.07M | Buy |
|
|||||
|
2022
Q3 | $1.43M | Buy |
|
|||||
|
2022
Q2 | $921K | Hold |
|
|||||
|
2022
Q1 | $921K | Sell |
|
|||||
|
2021
Q4 | $862K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $276K | Sell |
|
|||||
|
2020
Q3 | $478K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $337K | Buy |
|